loading...

Germany Biosimilars Business and Investment Opportunities Databook

According to BioIntel360, Germany's biosimilar market size is expected to record a CAGR of 27.7% during 2023-2027 to reach US$3,223.0 million by 2027, increasing from US$1,213.1 million in 2023. Over...

Germany Biosimilars Business and Investment Opportunities Databook – Q1 2023 Update
Summary
According to BioIntel360, Germany's biosimilar market size is expected to record a CAGR of 27.7% during 2023-2027 to reach US$3,223.0 million by 2027, increasing from US$1,213.1 million in 2023. Over the last five years, the sector has recorded a CAGR of 29.6%.

This report provides an in-depth data-centric analysis of the emerging opportunities in the biosimilars industry. It covers a detailed view of market size and forecast across various segments such as by product, type of cell, imaging technique, procedure, source of manufacturing,  applications, type of technology, and end users.

This section is a part of the title “Global Biosimilars Business and Investment Opportunities – Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals, and Competitive Landscape – Q1 2023 Update”.
Scope
This report provides an in-depth, data-centric analysis of the Germany biosimilar market 2018-2027. Below is a summary of key market segments:

Biosimilar Market Size By Product
• Monoclonal Antibody Biosimilars
• Insulin Biosimilar
• Biosimilar Interferons
• Other Biosimilar

Biosimilar Market Size By Type of Cell
• Mammalian
• Non-Mammalian

Biosimilar Market Size By Imaging Technique
• Magnetic Resonance Imaging Scanners
• Computed Tomography Scanners
• Positron Emission Tomography Scanners
• Others

Biosimilar Market Size By Procedure
• Invasive
• Non-Invasive

Biosimilar Market Size By Source of Manufacturing
• In-House
• Contract Manufacturing

Biosimilar Market Size By Applications
• Oncology
• Blood Disorders
• Growth Hormonal Deficiency
• Chronic & Autoimmune Disorders
• Infectious Diseases
• Others

Biosimilar Market Size By Type of Technology
• Mass Spectroscopy
• Chromatography
• Recombinant DNA technology
• Electrophoresis
• Others

Biosimilar Market Size By End User
• Hospital & Clinics
• Diagnostic Centres
• Others

Reason to buy
• In-depth understanding of biosimilars market dynamics: Understand market opportunity, industry dynamics, key trends and drivers across different market segments and sub-segments of the industry in Germany.

• Develop market-specific strategies: Identify growth segments and target specific opportunities to formulate your investment strategy; assess market-specific key trends, drivers, and risks in the industry.

• Get market share analysis by end users: Get a detailed analysis across different end users such as hospitals & clinics, diagnostic centres within the Germany.


Table of Contents
 1   Germany Biosimilar Market Size and Forecast, 2018-2027

2   Germany Biosimilar Market Share by Product, 2018-2027
2.1 Biosimilar Market Size by Monoclonal Antibody Biosimilars, 2018-2027
2.2 Biosimilar Market Size by Insulin Biosimilar, 2018-2027
2.3 Biosimilar Market Size by Biosimilar Interferons, 2018-2027
2.4 Biosimilar Market Size by Other Biosimilars, 2018-2027

3 Germany Biosimilar Market Share by Monoclonal Antibody Biosimilars, 2018-2027
4 Germany Biosimilar Market Share by Insulin Biosimilars, 2018-2027
5 Germany Biosimilar Market Share by Interferons Biosimilars, 2018-2027
6 Germany Biosimilar Market Share by Other Biosimilars, 2018-2027

7 Germany Biosimilar Market Share by Type of Cell, 2018-2027
7.1 Biosimilar Market Size by Mammalian Cell, 2018-2027
7.2 Biosimilar Market Size by Non-Mammalian Cell, 2018-2027

8 Germany Biosimilar Market Share by Imaging Technique, 2018-2027
8.1 Biosimilar Market Size by Magnetic Resonance Imaging Scanners, 2018-2027
8.2 Biosimilar Market Size by Computed Tomography Scanners, 2018-2027
8.3 Biosimilar Market Size by Positron Emission Tomography Scanners, 2018-2027
8.4 Biosimilar Market Size by Others, 2018-2027

9 Germany Biosimilar Market Share by Procedure, 2018-2027
9.1 Biosimilar Market Size by Invasive Procedure, 2018-2027
9.2 Biosimilar Market Size by Non-Invasive Procedure, 2018-2027

10 Germany Biosimilar Market Share by Source of Manufacturing, 2018-2027
10.1 Biosimilar Market Size by In-House, 2018-2027
10.2 Biosimilar Market Size by Contract Manufacturing, 2018-2027

11 Germany Biosimilar Market Share by Applications, 2018-2027
11.1 Biosimilar Market Size by Oncology, 2018-2027
11.2 Biosimilar Market Size by Blood Disorders, 2018-2027
11.3 Biosimilar Market Size by Growth Hormonal Deficiency, 2018-2027
11.4 Biosimilar Market Size by Chronic & Autoimmune Disorders, 2018-2027
11.5 Biosimilar Market Size by Infectious Diseases, 2018-2027
11.6 Biosimilar Market Size by Others, 2018-2027

12 Germany Biosimilar Market Share by Type of Technology, 2018-2027
12.1 Biosimilar Market Size by Mass Spectroscopy, 2018-2027
12.2 Biosimilar Market Size by Chromatography, 2018-2027
12.3 Biosimilar Market Size by Recombinant DNA Technology, 2018-2027
12.4 Biosimilar Market Size by Electrophoresis, 2018-2027
12.5 Biosimilar Market Size by Others, 2018-2027

13 Germany Biosimilar Market Share by End User, 2018-2027
13.1 Biosimilar Market Size by Hospital & Clinics, 2018-2027
13.2 Biosimilar Market Size by Diagnostic Centres, 2018-2027
13.3 Biosimilar Market Size by Others, 2018-2027
List Of Table
Table 1: Germany Biosimilar Market Size by Value (USD MM) 2018-2027 
Table 2: Germany Biosimilar Market Size by Monoclonal Antibody Biosimilars, by Value (USD MM), 2018-2027 
Table 3: Germany Biosimilar Market Size by Insulin Biosimilar, by Value (USD MM) 2018-2027 
Table 4: Germany Biosimilar Market Size by Biosimilar Interferons, by Value (USD MM) 2018-2027 
Table 5: Germany Biosimilar Market Size by Other Biosimilars, by Value (USD MM) 2018-2027 
Table 6: Germany Biosimilar Market Size by Mammalian Cell, by Value (UDS MM) 2018-2027 
Table 7: Germany Biosimilar Market Size by Non-Mammalian Cell, by Value (UDS MM) 2018-2027 
Table 8: Germany Biosimilar Market Size by Magnetic Resonance Imaging Scanners, by Value (USD MM), 2018-2027 
Table 9: Germany Biosimilar Market Size by Computed Tomography Scanners, by Value (USD MM), 2018-2027 
Table 10: Germany Biosimilar Market Size by Positron Emission Tomography Scanners, by Value (USD MM), 2018-2027 
Table 11: Germany Biosimilar Market Size by Others, by Value (USD MM), 2018-2027 
Table 12: Germany Biosimilar Market Size by Invasive Procedure (USD MM), 2018-2027 
Table 13: Germany Biosimilar Market Size by Non-Invasive Procedure (USD MM), 2018-2027 
Table 14: Germany Biosimilar Market Size by In-House, by Value (USD MM), 2018-2027 
Table 15: Germany Biosimilar Market Size by Contract Manufacturing, by Value (USD MM), 2018-2027 
Table 16: Germany Biosimilar Market Size by Oncology, by Value (USD MM), 2018-2027 
Table 17: Germany Biosimilar Market Size by Blood Disorders, by Value (USD MM), 2018-2027 
Table 18: Germany Biosimilar Market Size by Growth Hormonal Deficiency, by Value (USD MM), 2018-2027 
Table 19: Germany Biosimilar Market Size by Chronic & Autoimmune Disorders, by Value (USD MM), 2018-2027 
Table 20: Germany Biosimilar Market Size by Infectious Diseases, by Value (USD MM), 2018-2027 
Table 21: Germany Biosimilar Market Size by Others, by Value (USD MM), 2018-2027 
Table 22: Germany Biosimilar Market Size by Mass Spectroscopy, by Value (USD MM), 2018-2027 
Table 23: Germany Biosimilar Market Size by Chromatography, by Value (USD MM), 2018-2027 
Table 24: Germany Biosimilar Market Size by Recombinant DNA Technology, by Value (USD MM), 2018-2027 
Table 25: Germany Biosimilar Market Size by Electrophoresis, by Value (USD MM), 2018-2027 
Table 26: Germany Biosimilar Market Size by Others, by Value (USD MM), 2018-2027 
Table 27: Germany Biosimilar Market Size by Hospital & Clinics, by Value (USD MM), 2018-2027 
Table 28: Germany Biosimilar Market Size by Diagnostic Centres, by Value (USD MM), 2018-2027 
Table 29: Germany Biosimilar Market Size by Others, by Value (USD MM), 2018-2027 
List of figures
Figure 1: Germany Biosimilar Market Size by Value (USD MM) 2018-2027 
Figure 2: Germany Biosimilar Market Share by Product (%), 2018-2027 
Figure 3: Germany Biosimilar Market Size by Monoclonal Antibody Biosimilars, by Value (USD MM), 2018-2027 
Figure 4: Germany Biosimilar Market Size by Insulin Biosimilar, by Value (USD MM) 2018-2027 
Figure 5: Germany Biosimilar Market Size by Biosimilar Interferons, by Value (USD MM) 2018-2027 
Figure 6: Germany Biosimilar Market Size by Other Biosimilars, by Value (USD MM) 2018-2027 
Figure 7: Germany Biosimilar Market Share Monoclonal Antibody Biosimilars (%), 2018-2027 
Figure 8: Germany Biosimilar Market Share by Insulin Biosimilars (%), 2018-2027 
Figure 9: Germany Biosimilar Market Share by Interferons Biosimilars (%), 2018-2027 
Figure 10: Germany Biosimilar Market Share by Other Biosimilars (%), 2018-2027 
Figure 11: Germany Biosimilar Market Share by Type of Cell (%), 2018-2027 
Figure 12: Germany Biosimilar Market Share by Mammalian Cell, by Value (UDS MM) 2018-2027 
Figure 13: Germany Biosimilar Market Share by Non-Mammalian Cell, by Value (UDS MM) 2018-2027 
Figure 14: Germany Biosimilar Market Share by Imaging Technique (%), 2018-2027 
Figure 15: Germany Biosimilar Market Size by Magnetic Resonance Imaging Scanners, by Value (USD MM), 2018-2027 
Figure 16: Germany Biosimilar Market Size by Computed Tomography Scanners, by Value (USD MM), 2018-2027 
Figure 17: Germany Biosimilar Market Size by Positron Emission Tomography Scanners, by Value (USD MM), 2018-2027 
Figure 18: Germany Biosimilar Market Size by Others, by Value (USD MM), 2018-2027 
Figure 19: Germany Biosimilar Market Share by Procedure (%), 2018-2027 
Figure 20: Germany Biosimilar Market Size by Invasive Procedure (USD MM), 2018-2027 
Figure 21: Germany Biosimilar Market Size by Non-Invasive Procedure (USD MM), 2018-2027 
Figure 22: Germany Biosimilar Market Share by Source of Manufacturing (%), 2018-2027 
Figure 23: Germany Biosimilar Market Size by In-House, by Value (USD MM), 2018-2027 
Figure 24: Germany Biosimilar Market Size by Contract Manufacturing, by Value (USD MM), 2018-2027 
Figure 25: Germany Biosimilar Market Share by Applications (%), 2018-2027 
Figure 26: Germany Biosimilar Market Size by Oncology, by Value (USD MM), 2018-2027 
Figure 27: Germany Biosimilar Market Size by Blood Disorders, by Value (USD MM), 2018-2027 
Figure 28: Germany Biosimilar Market Size by Growth Hormonal Deficiency, by Value (USD MM), 2018-2027 
Figure 29: Germany Biosimilar Market Size by Chronic & Autoimmune Disorders, by Value (USD MM), 2018-2027 
Figure 30: Germany Biosimilar Market Size by Infectious Diseases, by Value (USD MM), 2018-2027 
Figure 31: Germany Biosimilar Market Size by Others, by Value (USD MM), 2018-2027 
Figure 32: Germany Biosimilar Market Share by Type of Technology (%), 2018-2027 
Figure 33: Germany Biosimilar Market Size by Mass Spectroscopy, by Value (USD MM), 2018-2027 
Figure 34: Germany Biosimilar Market Size by Chromatography, by Value (USD MM), 2018-2027 
Figure 35: Germany Biosimilar Market Size by Recombinant DNA Technology, by Value (USD MM), 2018-2027 
Figure 36: Germany Biosimilar Market Size by Electrophoresis, by Value (USD MM), 2018-2027 
Figure 37: Germany Biosimilar Market Size by Others, by Value (USD MM), 2018-2027 
Figure 38: Germany Biosimilar Market Share by End User (%), 2018-2027 
Figure 39: Germany Biosimilar Market Size by Hospital & Clinics, by Value (USD MM), 2018-2027 
Figure 40: Germany Biosimilar Market Size by Diagnostic Centres, by Value (USD MM), 2018-2027 
Figure 41: Germany Biosimilar Market Size by Others, by Value (USD MM), 2018-2027 


Request a Report
Email This Page to a colleague
Recipient #1
Recipient #2
Recipient #3
Recipient #4
Recipient #5
BioIntel360